| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of ...
STRATA gained on premarket trading after receiving Mexican regulatory approval for its TheraClearX acne treatment system.
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a global leader in in-office dermatologic technologies for the treatment of skin con...
STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to...